Glimedom M2 is a first choice combination of Glimepiride 2 mg + Metformin 500 mg (Prolonged release) to manage Hyperglycemia. This medicine achieves good glycemic control with better tolerability profile and improves the lipid profile. The combination can be used in Type-2 Diabetes and in Diabetes with or without Obesity.
USPs
Made in world class WHO-GMP Certified Facility
Excellent Packing.
Bilayer tablet for better drug control and stability.
Lower risk of hypoglycaemia & less weight gain than other sulfonylureas.
Combination achieves good glycemic control with better tolerability profile.
Reduces Blood Glucose more rapidly than Glipizide over first few weeks of treatment
Safe in Patients with Cardiovascular Disease.
Increased patient compliance due to small tablet size.